Indonesia authorises Sputnik V: RDIF
The total population of all countries where Sputnik V is approved for use now exceeds four billion people, which is more than half…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
Vir Biotechnology announces maiden marketing authorisation for sotrovimab in Australia
As part of its overarching effort to address COVID-19, the Australian Government recently announced an agreement to purchase…
India’s first COVID-19 mRNA vaccine developed in partnership with DBT-BIRAC
The Vaccine Subject Expert Committee (SEC) reviewed the interim phase-I data and found that HGCO19 was safe, tolerable and…
Israel’s COVID-19 vaccine boosters show signs of taming delta variant of coronavirus
Delta hit Israel in June, just as the country began to reap the benefits of one of the world’s fastest vaccine roll-outs
FDA approves first COVID-19 vaccine
Since 11th December, 2020, the Pfizer-BioNTech COVID-19 vaccine has been available under EUA in individuals 16 years of age and…
Centre provides over 57 crore vaccine doses to states and UTs
Over 13 crore doses are in the pipeline
J&J seeks Indian regulator’s nod for COVID vaccine trials on adolescents
Earlier this month, the government had given Emergency Use approval to J&J’s single-dose COVID vaccine in India
Zydus Cadila’s COVID vaccine ZyCoV-D gets approval for Emergency Use Authorisation
With EUA, ZyCoV-D has also become the first vaccine to be administered to those in the age group of 12-18 years in the country
AstraZeneca and Sputnik V vaccines’ combination show high immunogenicity, says RDIF
RDIF, the Gamaleya Center, AstraZeneca and R-Pharm signed a Memorandum of Intent aimed at cooperation in conducting a joint…
NRx Pharmaceuticals announces positive safety report for Zyesami in NIH-sponsored ACTIV-3 study in…
ACTIV-3 Critical Care is evaluating Zyesami and Remdesivir in critical COVID-19 patients as monotherapy, and in combination…
Sorrento’s vaccine shows promise against coronavirus, variants in animal studies
The sera of vaccinated mice showed neutralisation of infection caused by the original coronavirus and major variants of concern…
Mexico authorises emergency use of Moderna’s COVID vaccine
The Mexican official confirmed on his Twitter account yesterday that the Federal Commission for the Protection against Health…
NIH study shows no significant benefit of convalescent plasma for COVID-19 outpatients with early…
The formal conclusions from the trial appear in the current online issue of The New England Journal of Medicine
Second-generation mRNA COVID-19 vaccine candidate, CV2CoV, demonstrates improved immune response and…
Pre-clinical study provides evidence for improved immune responses with second-generation mRNA backbone jointly developed by…
Covishield’s booster dose desirable, says Cyrus Poonawalla
Since there was a shortage of the vaccine, the Modi government changed it to three months, but a two-month gap is ideal,"…
Bharat Biotech’s intra-nasal COVID vaccine gets DCGI nod for phase-II and -III trials
Phase-I clinical trial has been completed in age groups ranging from 18 to 60 years
Indian Immunologicals produces Covaxin drug substance
The output of Covaxin drug substance will be three-to-four million a month, and from December, will increase to 10 million a month
RDIF and Wockhardt partner to produce Sputnik V and Sputnik Light vaccines
The agreement was reached under the aegis of Enso Healthcare (part of Enso Group), RDIF's coordination partner for sourcing…
CDSCO approves study on mixing of Covaxin and Covishield doses
"The aim of the study is to assess the feasibility on whether a person can be given two different vaccine shots -- one each of…
Antibody levels predictive of Moderna’s vaccine efficacy, says study
The study, which has not yet been peer-reviewed, found that the Moderna vaccine was more effective in vaccine recipients with high…